Copy to clipboard 
Essent Biologics launched its Spectral demineralized bone matrix (DBM), a first of its kind human-derived DBM for 3D bioprinting and tissue engineering research applications. Essent Biologics will provide an osteoconductive DBM powder with osteoinductive potential derived from adult human cortical bone.
The company’s DBM powder is specifically formulated for bone tissue engineering research, complex in vitro bone models for drug discovery and other regenerative medicine research applications for musculoskeletal tissue. The product is an acid-extracted organic matrix from human bone and retains much of the components native to bone, such as calcium-based solids, inorganic phosphates and some trace of cell debris.
Essent Biologics’ DBM for research use is the ideal particle size for extrusion 3D bioprinting at 125-355µ particle size, recovered and processed without the use of antibiotics or animal products and tested for sterility and residual moisture.
Source: Essent Biologics
